000 01349 a2200385 4500
005 20250517213213.0
264 0 _c20190916
008 201909s 0 0 eng d
022 _a1550-7416
024 7 _a10.1208/s12248-018-0229-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTabrizi, Mohammad
245 0 0 _aIntegrative Pharmacology: Advancing Development of Effective Immunotherapies.
_h[electronic resource]
260 _bThe AAPS journal
_c04 2018
300 _a66 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Immunological
_xpharmacology
650 0 4 _aCombined Modality Therapy
_xmethods
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Development
_xmethods
650 0 4 _aDrug Evaluation, Preclinical
_xmethods
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aIntegrative Oncology
_xmethods
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPatient Selection
650 0 4 _aTranslational Research, Biomedical
_xmethods
650 0 4 _aTreatment Outcome
700 1 _aZhang, Daping
700 1 _aGanti, Vaishnavi
700 1 _aAzadi, Glareh
773 0 _tThe AAPS journal
_gvol. 20
_gno. 4
_gp. 66
856 4 0 _uhttps://doi.org/10.1208/s12248-018-0229-2
_zAvailable from publisher's website
999 _c28335170
_d28335170